These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10840419)

  • 21. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between size of renal cell carcinoma and its grade, stage, and histological subtype.
    Tabibi A; Parvin M; Abdi H; Bashtar R; Zamani N; Abadpour B
    Urol J; 2007; 4(1):10-3. PubMed ID: 17514604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
    Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
    Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical importance of intratumoral and normal renal parenchymal inflammatory cell infiltration in renal cell carcinoma.
    Soyupek S; Tulunay O; Armağan A; Hoscan B; Perk H
    Scand J Urol Nephrol; 2007; 41(5):387-91. PubMed ID: 17853031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
    Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
    J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicentricity and its associated factors in renal cell carcinoma.
    Li Q; Guan H; Zhang Q; Xue J; Wang F; Song X
    Chin Med J (Engl); 2002 Sep; 115(9):1341-4. PubMed ID: 12411108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic stratification of localized renal cell carcinoma by tumor size.
    Bedke J; Pritsch M; Buse S; Jakobi H; Elsaesser KH; Pahernik S; Haferkamp A; Hohenfellner M
    J Urol; 2008 Jul; 180(1):62-7. PubMed ID: 18485376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a.
    Siemer S; Lehmann J; Loch A; Becker F; Stein U; Schneider G; Ziegler M; Stöckle M
    J Urol; 2005 Jan; 173(1):33-7. PubMed ID: 15592020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposal of an improved prognostic classification for pT3 renal cell carcinoma.
    Terrone C; Gontero P; Volpe A; Porpiglia F; Bollito E; Zattoni F; Frea B; Tizzani A; Fontana D; Scarpa RM; Rossetti SR
    J Urol; 2008 Jul; 180(1):72-8. PubMed ID: 18485380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
    Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
    J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
    Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
    Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Satellite intrarenal tumor nodules in renal carcinoma. Therapeutic implications].
    Gutiérrez Baños JL; Martín García B; Hernández Rodríguez R; Portillo Martín JA; Correas Gómez MA; Dél Valle Schaan JI; Roca Edreira A; Vega Vega A; Villanueva Peña A
    Arch Esp Urol; 1996; 49(6):580-6. PubMed ID: 8929100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
    Jeon HG; Jeong IG; Kwak C; Kim HH; Lee SE; Lee E
    J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.